Opinions on Biotechnology

Skilled labor shortage biopharma manufacturing

Opinion 27 Sep 2023

Tackling the skilled labor shortage in biopharma manufacturing

By Brandy Bullen, founder & CEO of Sequoia Consulting Group The biopharma manufacturing sector stands at a critical juncture as it grapples with an increasingly pronounced skilled labor shortage. In…

September 27, 2023 - 6 minutesmins - By External Contributor

Opinion 20 Sep 2023

The next frontier in genomic technologies for rare diseases

By Neil Ward, VP and General Manager at PacBio EMEA It’s been 40 years since the passage of the Orphan Drug Act, which catalyzed the development of hundreds of therapies…

September 20, 2023 - 7 minutesmins - By External Contributor

Opinion 11 Jul 2023

Unlocking the power of mRNA technology

By Yochi Slonim, CEO and co-founder of Anima Biotech mRNA technology has gained widespread recognition due to its role in the development of vaccines, such as those used against COVID-19;…

July 11, 2023 - 4 minutesmins - By External Contributor

Opinion 10 Jul 2023

Five innovations to take RNA vaccines to the next level

By Venkata Indurthi, PhD, chief scientific officer, Aldevron During the COVID-19 pandemic, the world turned to a previously unused vaccine technology to rapidly develop desperately needed vaccines, providing immunity to…

July 10, 2023 - 4 minutesmins - By External Contributor

Opinion 30 Jun 2023

Virus tracking could be key to kidney transplant patients’ drug choices

By Dr Gregor Bond More than 15,000 Europeans undergo kidney transplants on average each year, and while medical advances have helped many recipients enjoy healthy lives, the risks of organ…

June 30, 2023 - 5 minutesmins - By External Contributor

Opinion 13 Jun 2023

How will European Commission proposals on data exclusivity and the bolar exemption affect pharma companies?

By Andrew Sharples, co-head of EIP’s UK litigation team In April, the European Commission published proposed legislation (specifically a new Regulation and a new Directive) aimed at reforming EU legislation…

June 13, 2023 - 5 minutesmins - By External Contributor

Opinion 9 May 2023

Where is innovation needed in cell therapy?

By Dr Ryan Roberts, cell processing lead at Cellular Origins Despite the rapidly emerging innovations in the field of cell and gene therapy, bottlenecks in cell therapy manufacturing processes are…

May 9, 2023 - 5 minutesmins - By External Contributor

Opinion 26 Apr 2023

Can mRNA vaccines tackle multiple diseases?

By Dr. Myriam Mendila, chief development officer of CureVac World Immunization Week is April 24-30, and it’s an important week to highlight the action needed and to promote the use…

April 26, 2023 - 9 minutesmins - By External Contributor

Opinion 26 Apr 2023

How to address declining vaccination rates in older adults

By Philip Dormitzer, global head of vaccines research and development, GSK The vaccines landscape has changed greatly over the last few years in light of the COVID-19 pandemic. New technologies…

April 26, 2023 - 5 minutesmins - By External Contributor

genetic sequencing DNA Human Genome Project HGP

Opinion 14 Apr 2023

20 years ago today: how genetic sequencing is changing lives since the Human Genome Project

By Dr. Radoje Drmanac, CSO of MGI and Complete Genomics Today marks the 20th anniversary of the completion of the first human genome sequence, which was mapped out on April…

April 14, 2023 - 6 minutesmins - By External Contributor

Opinion 24 Mar 2023

PAN-TB regimens to address growing TB drug resistance

By Dr. Charles Wells, head of therapeutics development at Gates Medical Research Institute As nearly one-quarter of the world’s population is presumed to be infected with Mycobacterium tuberculosis bacteria and…

March 24, 2023 - 5 minutesmins - By External Contributor

Opinion 8 Mar 2023

Should pharma be listening to social media to drive drug development?

By Thierry Escudier, consultant and strategic leader at The Pistoia Alliance The move towards patient centricity is gathering momentum, and digital technology is playing a huge role in this shift.…

March 8, 2023 - 5 minutesmins - By External Contributor

Opinion 28 Feb 2023

Life changing treatments for rare disease – a beacon of hope

By Sander Slootweg, managing partner, Forbion More than 300 million people around the globe are affected by a rare disease. This number does not even take into account the impact…

February 28, 2023 - 6 minutesmins - By External Contributor

Opinion 9 Feb 2023

How AI and ML can transform clinical research

By Gary Shorter, head of artificial intelligence at IQVIA Clinical trials are currently in an era of transformation through digitization, with much of the change being attributed to the integration…

February 9, 2023 - 4 minutesmins - By External Contributor

Opinion 3 Feb 2023

AI and experiments: new possibilities emerge in 2023

By Markus Gershater, co-founder and chief scientific officer, Synthace The buzz surrounding generative AI has reached fever pitch. It’s a technology so unique and fascinating that the breadth of possibility…

February 3, 2023 - 5 minutesmins - By External Contributor

Opinion 2 Feb 2023

How digital biomarker assays can harness the power of deep learning from clinical trials to the clinic

By Joe Oakley, MD, medical director of biomarker development, Paige Just as much of medicine has begun to undergo a digital transformation in the past decade, so has pathology. Now,…

February 2, 2023 - 8 minutesmins - By External Contributor

Opinion 1 Feb 2023

How AI is reshaping cancer diagnosis and treatment

By Soheila Borhani, School of Biomedical Informatics, University of Texas Health Science Center Since its first documented case circa 3000 B.C., cancer has remained at the top of the list…

February 1, 2023 - 4 minutesmins - By Jim Cornall

Opinion 1 Feb 2023

Computational chemistry and cancer

by Martin Slater, Cresset Discovery Computational chemistry offers a fast and innovative approach to drug discovery and is especially powerful when used in combination with biological testing to provide a…

February 1, 2023 - 3 minutesmins - By External Contributor

Opinion 18 Jan 2023

Innovation in life sciences requires collaboration and community

By Claudia Tripp and Katie Nelson, Kadans Science Partner Collaboration has underpinned some of the most impactful innovations of recent years. For example, the rapid development of the COVID vaccine…

January 18, 2023 - 5 minutesmins - By External Contributor

Opinion 12 Dec 2022

Artificial intelligence: a new era in rare genetic disease diagnosis

Despite the onset of the genomics era, rare disease diagnosis remains a challenge. Nostos Genomics’ co-founder, Rocío Acuña Hidalgo, and chief operating officer, Ansgar Lange, shed light on how artificial…

December 12, 2022 - 6 minutesmins - By External Contributor

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering